{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T14:57:34Z","timestamp":1777561054522,"version":"3.51.4"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T00:00:00Z","timestamp":1594598400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T00:00:00Z","timestamp":1594598400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Variants in the <jats:italic>SLC25A1<\/jats:italic> gene are associated with a severe neurometabolic disease, D-2- and L-2-hydroxyglutaric aciduria (D\/L-2-HGA). A report in 2014 presented the first account of congenital myasthenic syndrome (CMS) with mild intellectual disability (ID) caused by <jats:italic>SLC25A1<\/jats:italic>. To date, only two missense variants in <jats:italic>SLC25A1<\/jats:italic> have been linked to CMS.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Case presentations<\/jats:title>\n<jats:p>A Chinese boy presented fatigable muscular weakness, myasthenic crisis, epilepsy and developmental delay along with mild elevation of urinary 2-ketoglutarate (2-KG) and lactic acid levels. He showed a partial response to pyridostigmine. Genetic analysis using trio whole-exome sequencing (WES), Sanger sequencing, and cosegregation analyses revealed two novel pathogenic variants of <jats:italic>SLC25A1<\/jats:italic> (c.628C\u2009&gt;\u2009T, p.R210X; c.145G\u2009&gt;\u2009A, p.V49M).<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>We report a boy who carries novel compound heterozygous variants of <jats:italic>SLC25A1<\/jats:italic> and presents a phenotype intermediate between CMS and D\/L-2-HGA. This case expands the range of known phenotypes and genotypes associated with <jats:italic>SLC25A1<\/jats:italic>.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12883-020-01854-6","type":"journal-article","created":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T11:04:10Z","timestamp":1594638250000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["A case report of an intermediate phenotype between congenital myasthenic syndrome and D-2- and L-2-hydroxyglutaric aciduria due to novel SLC25A1 variants"],"prefix":"10.1186","volume":"20","author":[{"given":"Wenhui","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linmei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiyun","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bingbing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xihua","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5483-9205","authenticated-orcid":false,"given":"Shuizhen","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,13]]},"reference":[{"key":"1854_CR1","doi-asserted-by":"crossref","first-page":"13682","DOI":"10.1016\/S0021-9258(19)38701-0","volume":"268","author":"RS Kaplan","year":"1993","unstructured":"Kaplan RS, Mayor JA, Wood DO. The mitochondrial tricarboxylate transport protein. cDNA cloning, primary structure, and comparison with other mitochondrial transport proteins. J Biol Chem. 1993;268:13682\u201390.","journal-title":"J Biol Chem"},{"key":"1854_CR2","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.ajhg.2013.03.009","volume":"92","author":"B Nota","year":"2013","unstructured":"Nota B, Struys EA, Pop A, et al. Deficiency in SLC25A1, encoding the mitochondrial citrate carrier, causes combined D-2- and L-2- hydroxyglutaric aciduria. Am J Hum Genet. 2013;92:627\u201331.","journal-title":"Am J Hum Genet"},{"key":"1854_CR3","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1002\/ajmg.a.38574","volume":"176","author":"I Cohen","year":"2018","unstructured":"Cohen I, Staretz-Chacham O, Wormser O, et al. A novel homozygous SLC25A1 mutation with impaired mitochondrial complex V: possible phenotypic expansion. Am J Med Genet A. 2018;176:330\u20136.","journal-title":"Am J Med Genet A"},{"key":"1854_CR4","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/8904_2016_536","volume":"30","author":"A Smith","year":"2016","unstructured":"Smith A, McBride S, Marcadier JL, et al. Severe neonatal presentation of mitochondrial citrate carrier (SLC25A1) deficiency. JIMD Rep. 2016;30:73\u20139.","journal-title":"JIMD Rep"},{"key":"1854_CR5","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3233\/JND-140021","volume":"1","author":"A Chaouch","year":"2014","unstructured":"Chaouch A, Porcelli V, Cox D, et al. Mutations in the mitochondrial citrate carrier SLC25A1 are associated with impaired neuromuscular transmission. J Neuromuscul Dis. 2014;1:75\u201390.","journal-title":"J Neuromuscul Dis"},{"key":"1854_CR6","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/s41431-019-0506-2","volume":"28","author":"S Balaraju","year":"2020","unstructured":"Balaraju S, T\u00f6pf A, McMacken G, et al. Congenital myasthenic syndrome with mild intellectual disability caused by a recurrent SLC25A1 variant. Eur J Hum Genet. 2020;28:373\u20137.","journal-title":"Eur J Hum Genet"},{"key":"1854_CR7","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1111\/cge.13678","volume":"97","author":"A Al-Futaisi","year":"2020","unstructured":"Al-Futaisi A, Ahmad F, Al-Kasbi G, et al. Missense mutations in SLC25A1 are associated with congenital myasthenic syndrome type 23. Clin Genet. 2020;97:666\u20137.","journal-title":"Clin Genet"},{"key":"1854_CR8","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405\u201324.","journal-title":"Genet Med"},{"key":"1854_CR9","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.mam.2012.05.005","volume":"34","author":"F Palmieri","year":"2013","unstructured":"Palmieri F. The mitochondrial transporter family SLC25: identification, properties and physiopathology. Mol Asp Med. 2013;34:465\u201384.","journal-title":"Mol Asp Med"},{"key":"1854_CR10","doi-asserted-by":"publisher","first-page":"2362","DOI":"10.1016\/j.bbamcr.2016.03.007","volume":"1863","author":"F Palmieri","year":"2016","unstructured":"Palmieri F, Monn\u00e9 M. Discoveries, metabolic roles and diseases of mitochondrial carriers: a review. Biochim Biophys Acta. 2016;1863:2362\u201378.","journal-title":"Biochim Biophys Acta"},{"key":"1854_CR11","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.mcn.2008.07.027","volume":"39","author":"TM Maynard","year":"2008","unstructured":"Maynard TM, Meechan DW, Dudevoir ML, et al. Mitochondrial localization and function of a subset of 22q11 deletion syndrome candidate genes. Mol Cell Neurosci. 2008;39:439\u201351.","journal-title":"Mol Cell Neurosci"},{"key":"1854_CR12","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1038\/sj.mp.4001188","volume":"7","author":"NM Williams","year":"2002","unstructured":"Williams NM, Spurlock G, Norton N, et al. Mutation screening and LD mapping in the VCFS deleted region of chromosome 22q11 in schizophrenia using a novel DNA pooling approach. Mol Psychiatry. 2002;7:1092\u2013100.","journal-title":"Mol Psychiatry"},{"key":"1854_CR13","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1097\/WCO.0b013e328364dc0f","volume":"26","author":"D Hantai","year":"2013","unstructured":"Hantai D, Nicole S, Eymard B. Congenital myasthenic syndromes: an update. Curr Opin Neurol. 2013;26:561\u20138.","journal-title":"Curr Opin Neurol"},{"key":"1854_CR14","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.nmd.2005.05.001","volume":"15","author":"D Beeson","year":"2005","unstructured":"Beeson D, Hantai D, Lochmuller H, et al. 126th international workshop: congenital myasthenic syndromes, 24-26 September 2004, Naarden, the Netherlands. Neuromuscul Disord. 2005;15:498\u2013512.","journal-title":"Neuromuscul Disord"},{"key":"1854_CR15","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s10545-012-9462-5","volume":"35","author":"M Kranendijk","year":"2012","unstructured":"Kranendijk M, Struys EA, Salomons GS, et al. Progress in understanding 2-hydroxyglutaric acidurias. J Inherit Metab Dis. 2012;35:571\u201387.","journal-title":"J Inherit Metab Dis"},{"key":"1854_CR16","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s10545-017-0106-7","volume":"41","author":"A Pop","year":"2018","unstructured":"Pop A, Williams M, Struys EA, et al. An overview of combined D-2- and L-2-hydroxyglutaric aciduria: functional analysis of CIC variants. J Inherit Metab Dis. 2018;41:169\u201380.","journal-title":"J Inherit Metab Dis"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-020-01854-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-020-01854-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-020-01854-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,12]],"date-time":"2021-07-12T23:35:58Z","timestamp":1626132958000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-020-01854-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,13]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1854"],"URL":"https:\/\/doi.org\/10.1186\/s12883-020-01854-6","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,13]]},"assertion":[{"value":"16 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Children\u2019s Hospital of Fudan University, and written consent was obtained from the patient\u2019s parents to publish his clinical and genetic data. Our study is in accordance with the Declaration of Helsinki and the CARE guidelines\/methodology. All authors agree to the Publishing Statements of <i>BMC Neurology<\/i>.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written consent for publication was obtained from each of the family members. Written consent was obtained from the patient\u2019s parents to publish his clinical and genetic data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None of the authors has any competing interests or conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"278"}}